RMD
Resmed Inc.

2,032
Loading...
Loading...
News
all
press releases
Is it Worth Retaining ResMed Stock in Your Portfolio Now?
RMD's Mask and Device sales fuel growth, but macro headwinds and fierce competition continue to challenge its performance.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Here's Why ResMed (RMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·12d ago
News Placeholder
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
Zacks·24d ago
News Placeholder
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·26d ago
News Placeholder
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·28d ago
News Placeholder
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Zacks·28d ago
News Placeholder
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.
Zacks·1mo ago
News Placeholder
Resmed Australia shares hit record high on strong earnings
Investing.com--  Australian shares of Resmed (NYSE:RMD) Inc DRC (ASX:RMD) hit a record high on Friday after the medical devices maker clocked stronger than expected June quarter earnings.
investing.com·1mo ago
News Placeholder
Here's What Key Metrics Tell Us About ResMed (RMD) Q4 Earnings
The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks·1mo ago

Latest RMD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.